UK regulator authorises updated Pfizer-BioNTech COVID shot targeting JN.1 strain
(Reuters) -Britain’s health regulator said on Wednesday it has authorised Pfizer and BioNTech’s updated COVID-19 vaccine that targets the JN.1 subvariant for use in infants, children and adults. The Medicines and Healthcare products Regulatory Agency (MHRA) said it has approved four forms of the adapted Comirnaty JN.1 vaccine after reviewing its safety, quality and effectiveness. …
UK regulator authorises updated Pfizer-BioNTech COVID shot targeting JN.1 strain Read More »